Real Estate - Services
Compare Stocks
5 / 10Stock Comparison
NEN vs AIV vs NHI vs AVB vs EQR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
REIT - Healthcare Facilities
REIT - Residential
REIT - Residential
NEN vs AIV vs NHI vs AVB vs EQR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Real Estate - Services | REIT - Residential | REIT - Healthcare Facilities | REIT - Residential | REIT - Residential |
| Market Cap | $168M | $596M | $3.54B | $25.77B | $24.82B |
| Revenue (TTM) | $89M | $193M | $402M | $3.04B | $3.12B |
| Net Income (TTM) | $6M | $554M | $148M | $1.05B | $954M |
| Gross Margin | 49.1% | 55.2% | 52.4% | 67.0% | 46.3% |
| Operating Margin | 24.4% | 66.3% | 35.6% | 30.1% | 28.5% |
| Forward P/E | 34.7x | 1.1x | 21.6x | 37.6x | 50.9x |
| Total Debt | $528M | $0.00 | $1.16B | $9.33B | $8.78B |
| Cash & Equiv. | $26.67B | $395M | $20M | $187M | $56M |
NEN vs AIV vs NHI vs AVB vs EQR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| New England Realty … (NEN) | 100 | 119.1 | +19.1% |
| Apartment Investmen… (AIV) | 100 | 86.6 | -13.4% |
| National Health Inv… (NHI) | 100 | 131.7 | +31.7% |
| AvalonBay Communiti… (AVB) | 100 | 118.7 | +18.7% |
| Equity Residential (EQR) | 100 | 109.4 | +9.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NEN vs AIV vs NHI vs AVB vs EQR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NEN is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 7 yrs, beta 0.14, yield 8.0%
- Lower volatility, beta 0.14, current ratio 4247.47x
- PEG 1.00 vs EQR's 10.00
- Beta 0.14, yield 8.0%, current ratio 4247.47x
AIV carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 86.9% 10Y total return vs NHI's 59.2%
- 287.7% margin vs NEN's 6.8%
- 69.3% yield, 1-year raise streak, vs EQR's 4.1%
- 29.6% ROA vs NEN's 1.3%
NHI ranks third and is worth considering specifically for growth exposure.
- Rev growth 12.9%, EPS growth -3.5%, 3Y rev CAGR 10.8%
- 12.9% FFO/revenue growth vs AIV's -100.0%
- +0.9% vs NEN's -21.5%
AVB lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, EQR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.9% FFO/revenue growth vs AIV's -100.0% | |
| Value | Lower P/E (34.7x vs 50.9x), PEG 1.00 vs 10.00 | |
| Quality / Margins | 287.7% margin vs NEN's 6.8% | |
| Stability / Safety | Beta 0.14 vs AIV's 0.69 | |
| Dividends | 69.3% yield, 1-year raise streak, vs EQR's 4.1% | |
| Momentum (1Y) | +0.9% vs NEN's -21.5% | |
| Efficiency (ROA) | 29.6% ROA vs NEN's 1.3% |
NEN vs AIV vs NHI vs AVB vs EQR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NEN vs AIV vs NHI vs AVB vs EQR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHI leads in 2 of 6 categories
AIV leads 1 • NEN leads 1 • AVB leads 0 • EQR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AIV leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EQR is the larger business by revenue, generating $3.1B annually — 35.0x NEN's $89M. Profitability is closely matched — net margins range from 2.9% (AIV) to 6.8% (NEN). On growth, NHI holds the edge at +28.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $89M | $193M | $402M | $3.0B | $3.1B |
| EBITDAEarnings before interest/tax | $45M | $186M | $229M | $1.8B | $1.9B |
| Net IncomeAfter-tax profit | $6M | $554M | $148M | $1.1B | $954M |
| Free Cash FlowCash after capex | $27M | -$230M | $229M | $1.5B | $1.3B |
| Gross MarginGross profit ÷ Revenue | +49.1% | +55.2% | +52.4% | +67.0% | +46.3% |
| Operating MarginEBIT ÷ Revenue | +24.4% | +66.3% | +35.6% | +30.1% | +28.5% |
| Net MarginNet income ÷ Revenue | +6.8% | +2.9% | +36.8% | +34.6% | +30.6% |
| FCF MarginFCF ÷ Revenue | +30.7% | -119.5% | +56.9% | +49.7% | +42.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.7% | -3.4% | +28.9% | +3.7% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -133.3% | +25.9% | +10.8% | -40.9% | -64.2% |
Valuation Metrics
NEN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 1.1x trailing earnings, AIV trades at a 97% valuation discount to NEN's 34.7x P/E. Adjusting for growth (PEG ratio), NEN offers better value at 1.00x vs AVB's 5.36x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $168M | $596M | $3.5B | $25.8B | $24.8B |
| Enterprise ValueMkt cap + debt − cash | -$26.0B | $201M | $4.7B | $34.9B | $33.6B |
| Trailing P/EPrice ÷ TTM EPS | 34.71x | 1.10x | 24.20x | 25.07x | 22.77x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 21.58x | 37.61x | 50.91x |
| PEG RatioP/E ÷ EPS growth rate | 1.00x | — | — | 5.36x | 4.47x |
| EV / EBITDAEnterprise value multiple | -1.12x | 2.01x | 16.82x | 19.11x | 15.68x |
| Price / SalesMarket cap ÷ Revenue | 1.89x | — | 9.36x | 8.48x | 8.00x |
| Price / BookPrice ÷ Book value/share | — | 1.15x | 2.23x | 2.22x | 2.26x |
| Price / FCFMarket cap ÷ FCF | 0.01x | — | 16.08x | 18.23x | 19.25x |
Profitability & Efficiency
NHI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
AIV delivers a 162.9% return on equity — every $100 of shareholder capital generates $163 in annual profit, vs $8 for EQR. NHI carries lower financial leverage with a 0.76x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVB's 0.79x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs AIV's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +162.9% | +9.8% | +8.8% | +8.4% |
| ROA (TTM)Return on assets | +1.3% | +29.6% | +5.3% | +4.8% | +4.6% |
| ROICReturn on invested capital | — | +4.2% | +5.6% | +3.3% | +4.2% |
| ROCEReturn on capital employed | +4.9% | +2.3% | +8.0% | +4.4% | +5.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | — | — | 0.76x | 0.79x | 0.77x |
| Net DebtTotal debt minus cash | -$26.1B | -$395M | $1.1B | $9.1B | $8.7B |
| Cash & Equiv.Liquid assets | $26.7B | $395M | $20M | $187M | $56M |
| Total DebtShort + long-term debt | $528M | $0 | $1.2B | $9.3B | $8.8B |
| Interest CoverageEBIT ÷ Interest expense | 1.17x | 0.70x | 3.45x | 5.07x | 5.58x |
Total Returns (Dividends Reinvested)
NHI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHI five years ago would be worth $12,999 today (with dividends reinvested), compared to $11,036 for EQR. Over the past 12 months, NHI leads with a +0.9% total return vs NEN's -21.5%. The 3-year compound annual growth rate (CAGR) favors NHI at 19.4% vs NEN's -0.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.8% | -3.4% | -3.7% | +3.6% | +9.1% |
| 1-Year ReturnPast 12 months | -21.5% | -1.6% | +0.9% | -8.4% | -2.5% |
| 3-Year ReturnCumulative with dividends | -0.4% | +6.8% | +70.3% | +14.5% | +17.4% |
| 5-Year ReturnCumulative with dividends | +26.2% | +29.2% | +30.0% | +16.3% | +10.4% |
| 10-Year ReturnCumulative with dividends | +49.2% | +86.9% | +59.2% | +33.1% | +32.0% |
| CAGR (3Y)Annualised 3-year return | -0.1% | +2.2% | +19.4% | +4.6% | +5.5% |
Risk & Volatility
Evenly matched — NHI and EQR each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than AIV's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EQR currently trades 92.3% from its 52-week high vs AIV's 47.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | 0.69x | -0.08x | 0.48x | 0.38x |
| 52-Week HighHighest price in past year | $79.85 | $8.87 | $90.94 | $211.65 | $71.80 |
| 52-Week LowLowest price in past year | $56.00 | $3.94 | $68.80 | $160.09 | $57.58 |
| % of 52W HighCurrent price vs 52-week peak | +74.8% | +47.9% | +80.4% | +87.5% | +92.3% |
| RSI (14)Momentum oscillator 0–100 | 50.2 | 51.3 | 29.0 | 66.3 | 66.9 |
| Avg Volume (50D)Average daily shares traded | 986 | 3.2M | 323K | 931K | 2.3M |
Analyst Outlook
Evenly matched — AIV and EQR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AIV as "Hold", NHI as "Hold", AVB as "Hold", EQR as "Hold". Consensus price targets imply 135.3% upside for AIV (target: $10) vs 3.5% for AVB (target: $192). For income investors, AIV offers the higher dividend yield at 69.32% vs AVB's 3.77%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $10.00 | $85.40 | $191.70 | $70.15 |
| # AnalystsCovering analysts | — | 3 | 18 | 42 | 46 |
| Dividend YieldAnnual dividend ÷ price | +8.0% | +69.3% | +4.9% | +3.8% | +4.1% |
| Dividend StreakConsecutive years of raises | 7 | 1 | 1 | 3 | 8 |
| Dividend / ShareAnnual DPS | $4.80 | $2.95 | $3.61 | $6.99 | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +0.0% | 0.0% | +1.9% | +1.1% |
NHI leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). AIV leads in 1 (Income & Cash Flow). 2 tied.
NEN vs AIV vs NHI vs AVB vs EQR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NEN or AIV or NHI or AVB or EQR a better buy right now?
For growth investors, National Health Investors, Inc.
(NHI) is the stronger pick with 12. 9% revenue growth year-over-year, versus -100. 0% for Apartment Investment and Management Company (AIV). Apartment Investment and Management Company (AIV) offers the better valuation at 1. 1x trailing P/E, making it the more compelling value choice. Analysts rate Apartment Investment and Management Company (AIV) a "Hold" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NEN or AIV or NHI or AVB or EQR?
On trailing P/E, Apartment Investment and Management Company (AIV) is the cheapest at 1.
1x versus New England Realty Associates Limited Partnership at 34. 7x. On forward P/E, National Health Investors, Inc. is actually cheaper at 21. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AvalonBay Communities, Inc. wins at 8. 04x versus Equity Residential's 10. 00x.
03Which is the better long-term investment — NEN or AIV or NHI or AVB or EQR?
Over the past 5 years, National Health Investors, Inc.
(NHI) delivered a total return of +30. 0%, compared to +10. 4% for Equity Residential (EQR). Over 10 years, the gap is even starker: AIV returned +86. 9% versus EQR's +32. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NEN or AIV or NHI or AVB or EQR?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus Apartment Investment and Management Company's 0. 69β — meaning AIV is approximately -917% more volatile than NHI relative to the S&P 500. On balance sheet safety, National Health Investors, Inc. (NHI) carries a lower debt/equity ratio of 76% versus 79% for AvalonBay Communities, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NEN or AIV or NHI or AVB or EQR?
By revenue growth (latest reported year), National Health Investors, Inc.
(NHI) is pulling ahead at 12. 9% versus -100. 0% for Apartment Investment and Management Company (AIV). On earnings-per-share growth, the picture is similar: Apartment Investment and Management Company grew EPS 623. 0% year-over-year, compared to -61. 4% for New England Realty Associates Limited Partnership. Over a 3-year CAGR, NHI leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NEN or AIV or NHI or AVB or EQR?
Apartment Investment and Management Company (AIV) is the more profitable company, earning 287.
7% net margin versus 6. 8% for New England Realty Associates Limited Partnership — meaning it keeps 287. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AIV leads at 66. 3% versus 24. 4% for NEN. At the gross margin level — before operating expenses — AVB leads at 67. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NEN or AIV or NHI or AVB or EQR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, AvalonBay Communities, Inc. (AVB) is the more undervalued stock at a PEG of 8. 04x versus Equity Residential's 10. 00x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, National Health Investors, Inc. (NHI) trades at 21. 6x forward P/E versus 50. 9x for Equity Residential — 29. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AIV: 135. 3% to $10. 00.
08Which pays a better dividend — NEN or AIV or NHI or AVB or EQR?
All stocks in this comparison pay dividends.
Apartment Investment and Management Company (AIV) offers the highest yield at 69. 3%, versus 3. 8% for AvalonBay Communities, Inc. (AVB).
09Is NEN or AIV or NHI or AVB or EQR better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 9% yield). Both have compounded well over 10 years (NHI: +59. 2%, AIV: +86. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NEN and AIV and NHI and AVB and EQR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NEN is a small-cap income-oriented stock; AIV is a small-cap deep-value stock; NHI is a small-cap income-oriented stock; AVB is a mid-cap income-oriented stock; EQR is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.